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Abstract
Hyperspectral imaging (HSI) technologies have been used extensively in medical research, targeting
various biological phenomena and multiple tissue types. Their high spectral resolution over a wide
range of wavelengths enables acquisition of spatial information corresponding to different light-
interacting biological compounds. This review focuses on the application of HSI to monitor brain
tissue metabolism and hemodynamics in life sciences. Different approaches involving HSI have been
investigated to assess and quantify cerebral activity, mainly focusing on: (1) mapping tissue oxygen
delivery through measurement of changes in oxygenated (HbO2) and deoxygenated (HHb)
hemoglobin; and (2) the assessment of the cerebral metabolic rate of oxygen (CMRO2) to estimate
oxygen consumption by brain tissue. Finally, we introduce future perspectives of HSI of brain
metabolism, including its potential use for imaging optical signals from molecules directly involved
in cellular energy production. HSI solutions can provide remarkable insight in understanding cerebral
tissue metabolism and oxygenation, aiding investigation on brain tissue physiological processes.
Keywords: biomedical optics, hyperspectral imaging, brain metabolism, brain hemodynamics
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1. Introduction
In recent years, hyperspectral imaging (HSI) has emerged as a
promising optical technology for biomedical applications, pri-
marily for life sciences research, but also aimed at non-invasive
diagnosis and image-guided surgery [1–4]. It is capable of
providing real-time quantitative information for several biolo-
gical processes in both healthy and diseased tissues. In part-
icular, this is achieved by measuring the intensity changes of
numerous different wavelengths of reﬂected, emitted or ﬂuor-
escent light after interacting with tissue. These light intensity
changes occur due to variations in the optical properties (mainly
scattering and absorption) of the target tissue, that can be
accounted for both modiﬁcations in the biological structure of
its components and changes in the concentrations of intrinsic
light-absorbing or light-emitting chromophores [5, 6].
HSI systems have then been used to investigate and
detect multiple biological phenomena in healthy tissue and in
various diseases, such as quantiﬁcation of blood oxygenation
and perfusion [7–10], cancer type differentiation and cancer
tissue metabolism [11–13], retinal diseases [14–16], cardio-
vascular conditions [17–19] and haemorrhagic shock [20, 21].
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Different types of tissues have also been targeted using HSI
setups, including skin [22–24], oral and gastrointestinal tissue
[25–27], breast [28, 29] and brain [30–33].
The present review article aims speciﬁcally to summarize
the literature regarding the application of HSI for monitoring and
investigating brain tissue hemodynamics and metabolism, with
major emphasis on the latter phenomenon. This encompasses
non-pathological cerebral tissue during both regular metabolic
activity (e.g. functional activation and response to different sti-
muli) and brain metabolism under abnormal conditions, such as
tissue hypoxia, hyperoxia and ischemia. The study of cerebral
tissue metabolism and hemodynamics is important for devel-
oping a deeper and broader understanding of brain tissue phy-
siology, as well as to accurately investigate and map cerebral
activity following neuronal activation [34, 35]. Furthermore,
monitoring brain metabolism in certain pathological conditions,
such as neurodegenerative diseases and brain injuries, potentially
allows identiﬁcation of irregular tissue functionality [36–38].
The possibilities of future potential hyperspectral approaches
explicitly for brain metabolic imaging based on established
optical solutions will be also discussed.
A brief overview on the application and use of light in
brain tissue imaging, with its advantages and limitations, will
be provided ﬁrst. Then, the different deﬁnitions of HSI fre-
quently used in the literature will be discussed, with the intent
of precisely stating which concept of hyperspectral is applied
to the main topic of this article. A general summary of the
different components and speciﬁc instrumentation used in
HSI solutions for monitoring brain metabolism and hemo-
dynamics will follow, together with an outline of the major
hyperspectral acquisition techniques. At the end of the current
section, an introduction to the main biological mechanisms of
brain tissue metabolism and the related optical measurable
signals will be then presented.
Afterwards, the article will present HSI for monitoring
oxygen delivery and hemodynamics in brain tissue. It is impor-
tant to clarify that, although a relation between oxygenation of
brain tissue and its metabolic activation has been extensively
demonstrated [34, 35, 39–41], measuring spatially localized
variations in the concentration of oxy-hemoglobin (HbO2) and
deoxy-hemoglobin (HHb) does not directly quantify brain
metabolism [42, 43]. Therefore, speciﬁc methods have been
proposed and explored in order to also quantitatively monitor
metabolic activity in cerebral tissue. The core part of this review
will concentrate on their current and future applications with HSI.
It will focus principally on two main aspects of brain metabolic
monitoring through HSI that includes: (1) quantiﬁcation of brain
oxygen metabolism, which involves imaging cerebral hemody-
namics and estimating the cerebral metabolic rate of oxygen
(CMRO2); and (2) brain tissue energetics, where energy pro-
duction inside cerebral cells is quantiﬁed by imaging speciﬁc
light-interacting molecules involved in cellular aerobic respiration
and in adenosine triphosphate (ATP) synthesis.
1.1. The use of light to image and monitor the brain
In vivo optical brain imaging modalities, such as HSI, exploit
the interaction of light and biological tissue at diverse
wavelengths in the electromagnetic spectrum, with the pur-
pose of retrieving physiological information. This has many
advantages, the most important are the excellent sensitivity to
functional changes and the speciﬁcity of particular optical
signatures to fundamental molecules and substances in the
body, generating what is commonly known as intrinsic con-
trast [31]. As mentioned previously, this contrast depends on
the different interactions between light and tissue. Light
absorption and scattering are the two chief phenomena
occurring when light travels through living matter, such as the
brain. Absorption by speciﬁc chromophores, particularly
water and hemoglobin, limits depth penetration of light into
cerebral tissue in the visible range (400–700 nm) to only few
mm. However, brain cortex (as any biological tissue in broad
sense) is relatively transparent to light in the near-infrared
(NIR) range, between 650 and 1350 nm (known as optical
window), allowing its use for non-invasive mapping of brain
hemodynamics and functional activity [1, 5, 6]. Nonetheless,
there are critical restrictions to image quality when optical
imaging is performed non-invasively, due to the inﬂuence of
scattering from different layers of the head (primarily skull
and scalp). In the NIR range, the brain has high scattering
properties due to its structural inhomogeneity [5]. Thus, light
diffuses in cerebral tissue, undergoing multiple scattering
events in short distances. This causes important limitations to
the spatial resolution achievable by any optical imaging
systems, since an ideal point illumination will not produce a
corresponding point image but a more blurred area. Such an
imaging response is called a tissue point-spread function and
the blurring effect becomes more signiﬁcant for deeper pro-
pagation distances [44]. Therefore, an intrinsic trade-off exists
between spatial resolution and depth of penetration for non-
invasive optical imaging of the brain.
Animal studies involving the thinning of the skull or
even the complete uncovering of the cortex offer direct
acquisition of high-resolution images of the surface of the
living brain with minimal effects on its normal functions and
physiological state. The elimination of the scalp and the skull,
with skin layers and vasculature, excludes contamination of
the optical signal from sources other than the illuminated
brain tissue, as well as greatly enhances both light penetration
in the cortex and spatial resolution of the images. Addition-
ally, the smaller the size of the brain of the targeted animals
is, the greater the detrimental effect of light scattering in tissue
is mitigated, thus gradually improving sensitivity and quan-
titation power of the optical data. The exposed cortex is thus
the preferred imaging target for the HSI studies reported in
this article. In particular, the uncovering of the cerebral cortex
allows the use of spectral bands in the visible range for
imaging, permitting a higher contrast due to the greater
absorption in this portion of the electromagnetic spectrum
from major chromophores in the brain, primarily the two
forms of hemoglobin (as explained in section 2).
Finally, it is important to mention also the role of optical
modeling, which is usually implemented to numerically
simulate light transport and diffusion in biological tissue and
thus to greatly improve image reconstruction and quantiﬁca-
tion, as well as to estimate optical pathlengths. Monte Carlo
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stochastic approaches are among the most used and are able
to generate very accurate modeling of light propagation inside
general-shaped domains and multi-layered media, with the
advantage of providing also speciﬁc information on indivi-
dual photon tracks and histories [6, 45].
1.2. Definition of HSI for brain metabolism and hemodynamics
HSI has been commonly deﬁned in a broad and general sense
as the acquisition of two-dimensional (2D) images across a
wide range of the electromagnetic spectrum [1–3, 46, 47].
This deﬁnition has sometimes corresponded to a similarly
parallel concept in single-point optical spectroscopy, known
as broadband spectroscopy [48]. The precise and exact
number of wavelengths to be used in HSI has never been
clearly established and it frequently depends on the applica-
tion, stretching from only two wavelengths up to a few
hundred. For this reason, the boundary dividing HSI and
another similar technique, i.e. multispectral imaging (MSI), is
not always distinctly delineated and these two optical imaging
approaches can occasionally overlap in the literature, being
often subject to arbitrary interpretations. For example,
Hillman [31] simply deﬁned HSI as the measurement of two
or more wavelengths. On the contrary, other authors [49–53]
Figure 1. Difference between hyperspectral (top) and multispectral (bottom) imaging. The top image shows the creation of the hypercube
using a large number of contiguous spectral bands. The result gives a complete spectrum for each pixel (xi, yi). In the bottom image, only
discrete and discontinuous portions of the spectral range are considered.
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stated that tens to hundreds of contiguous spectral bands must
be involved to create a typical hyperspectral data cube, also
known as hypercube (i.e. a three-dimensional dataset con-
taining the spatial coordinates of each pixel along the x and y
axes, plus the spectral information along the z axis).
Spectral sampling and resolution are generally con-
sidered the key factors that distinguish HSI and MSI
(ﬁgure 1): while MSI focuses on discrete and relatively
spaced wavelength bands, HSI primarily utilizes very narrow
and adjacent spectral bands over a continuous spectral range,
as to reconstruct the spectrum of each pixel in the image
[1, 4, 20, 53]. Again, the width of these bands and their
mutual separation are not speciﬁcally deﬁned, though they are
typically below 10–20 nm [47].
The spectral range covered by a HSI system and the
number of wavelength bands it utilizes usually depends on its
speciﬁc mode of acquisition of the hypercube data. These
modes will be discussed in the next paragraph. A larger
number of wavelength bands with high spectral resolution
and sampling typically requires a more complex HSI instru-
mentation and it is associated with a larger amount of data to
be collected, stored and processed.
For the present review, a hyperspectral system and setup
is considered to be any imaging system that involves the use
and detection of three or more contiguous wavelength bands,
thus slightly extending the deﬁnition of Hillman [31]. How-
ever, spectral resolution will be still taken into account as a
key aspect. The reason behind this choice is related to the
narrowness of the spectral ranges typically analyzed for
retrieving quantitative information from speciﬁc chromo-
phores and molecules involved in metabolic activity in vivo.
Nonetheless, high spectral sampling and resolution typical of
HSI technologies are still strongly required to identify these
compounds and to adequately quantify and localize them.
Optimal selection of the spectral range and of the speciﬁc
wavelength bands is also a crucial point in the application of
HSI to brain imaging. As stated previously, the visible range
is usually the preferred choice for targeting the exposed
cortex, while the NIR range can provide a solution for non-
invasive and diagnostic approaches. In many cases, optim-
ization of the choice of the spectral bands leads to the use of a
relatively small number of wavelengths (typically between six
and ten) corresponding to precise portions of the absorption or
ﬂuorescence spectra of the targeted chromophores. This has
the advantage of reducing the complexity of the involved
hyperspectral instrumentation and also the sheer size of the
hyperspectral data to handle.
1.3. HSI techniques and instrumentation for brain tissue
monitoring
The spectral and spatial information that constitutes the
hypercube can be collected in different ways, according to
the conﬁguration of the HSI system and its instrumentation.
The three main hyperspectral image acquisition modes can be
summarized as: (1) spectral scanning modes, (2) spatial
scanning modes and (3) snapshot modes, also called snapshot
imaging spectrometry [1, 49, 54].
Spectral scanning modes consist of the sequential
acquisition of 2D images of the target at each required
wavelength band. Every acquired image corresponds essen-
tially to a single spatial slice (x, y) of the hypercube. At each
image acquisition, the hypercube is reconstructed by piling up
all the slices along the spectral dimension (λ). Spectral
scanning acquisition can be implemented in various ways,
primarily by either ﬁltering the light emitted by the illumi-
nation source (excitation-side) or ﬁltering the reﬂected/
emitted light before detection (emission-side). For this pur-
pose, different ﬁltering technologies can be used. Among
these, mechanical ﬁltering via ﬁlter wheels is one of the most
widely employed [1, 4, 31]. It is advantageous for its low
complexity and cost, though the number of spectral bands that
can be installed in the wheel is usually limited (up to 8–10),
as well as the spectral resolution and the selection of the
speciﬁc wavelengths required. In addition, the switching
speed between ﬁlters is typically slow [1]. Tunable ﬁlters,
such as acousto-optical tunable ﬁlters (AOTFs) and liquid
crystal tunable ﬁlters (LCTFs), can provide much higher
image quality and better spectral resolution and sampling over
a wide range of wavelengths. They also offer rapid tuning
rates that can signiﬁcantly reduce the total acquisition time for
a single hypercube [1, 49]. As an alternative to ﬁltering,
spectral scanning can also be performed by directly switching
between multiple sources with narrow spectral emission, such
as light-emitting diodes.
Spatial scanning modes acquire spatio-spectral informa-
tion at each scan of succeeding portions of the 2D image.
They can collect the complete spectrum (λ) of each pixel of
the image, point by point, and then reconstruct the entire
hypercube at every spatial location (x, y). This approach is
commonly called point scanning or whiskbroom scanning.
Alternatively, the spectral data (x, λ) of a single array of
pixels can be acquired at each scan to build the hyperspectral
dataset line by line along the other spatial dimension (y). In
this case, the acquisition mode is known as linear scanning or
pushbroom scanning. Both of the two modalities require a
relative movement between the subject and the hyperspectral
setup and, compared to spectral scanning, do not provide a
real-time display of the whole ﬁeld of view (FOV) of the
image. Collimating devices and optical spectrometers are
typically necessary to accomplish the spatial scanning pro-
cedure: pinhole apertures (for point scanning) or slits (linear
scanning) collimate light to image (or illuminate) only a
portion of the FOV; while dispersive devices, such as dif-
fraction gratings and prisms, are used to separate the poly-
chromatic light into its constituent wavelengths [1].
Snapshot HSI techniques encompass a number of acquisi-
tion approaches that normally share the capability of recording
every image at each spectral band simultaneously, within a
single integration time of the detector. These modes totally
eliminate the need of scanning procedures. Most snapshot
techniques used for brain tissue metabolic monitoring rely on
dispersive elements, like prism arrays and mirrors, in order to
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split the FOV of the imaged subject into sections (slices or
portions of the image) that are then separated in their spectral
constituents. After that, the sections are distributed and recorded
over the whole detecting area. By doing that, the detector is
divided in regions that embed the complete spatial and spectral
information of the target, from which the hypercube has to be
reconstructed. These types of snapshot modalities are usually
called image mapping spectrometers (IMS) [49, 55]. The sim-
plest conﬁguration involves multiplexing the detector area of the
full image at each wavelength. Alternatively, image slicing
spectrometers separate the image in slices. However, IMS
approaches are generally limited by the dimension of the
detector area, which consequently restricts the size of the
hypercube and the spatial resolution of the images [49, 55].
Generally, HSI acquisition via spectral or spatial scan-
ning provides higher spectral resolution and enables the use of
a greater number of wavelengths bands, although at the cost
of a longer imaging time. They are also more sensitive to
motion artifacts and distortions in the ﬁnal reconstructed
image, which may occur if the subject moves during the time
of a single hypercube acquisition. This may produce sig-
niﬁcant issues especially for in vivo applications [1, 4, 54].
Contrariwise, snapshot HSI systems have the advantage of
reducing the acquisition time of each hyperspectral dataset,
since they can capture an entire hypercube in just a single
detector integration period, without the need for ﬁltering or
relative movement between the subject and the HSI system.
Nonetheless, this is typically obtained at the expenses of both
spectral sampling and spatial resolution, due to the very large
volume of data handled [1, 4, 55].
In almost every application of HSI in imaging of brain
metabolism and hemodynamics, illumination of the target is
normally delivered by white light sources encompassing a
broad range of wavelengths, e.g. halogen lamps or gas dis-
charge lamps. Laser sources are not common, although they
may be used in HSI setups for complementary imaging
techniques, such as for laser speckle contrast imaging (see
section 3). Still, an alternative way to provide broadband
illumination is represented by supercontinuum lasers, espe-
cially in spectral acquisition mode, due to their large spectral
range (typically covering visible and infrared emission), high
intensity and power output, as well as for their fast repetition
rates. However, they are typically more expensive compared
to conventional light sources.
For light intensity detection, charge-coupled devices
(CCDs) are the most extensively used sensor instruments for
hyperspectral measurements of brain metabolism and hemo-
dynamics in any acquisition mode, due to their high quantum
efﬁciency and low dark noise [1]. They represent a well-
established detection technology at relatively moderate cost
and can cover large spectral ranges, spanning from visible to
NIR light. Nonetheless, complementary metal-oxide sensors
(CMOS), particularly the so-called scientiﬁc CMOS (or
sCMOS), are rapidly emerging as alternative imaging detec-
tors for the light intensities involved in HSI, as they can
combine fast frame rates with high dynamic ranges.
Commercial hyperspectral cameras, mostly based on snapshot
mode, have also started to appear on the market in recent
years and have been used for brain tissue metabolic and
hemodynamic imaging. Spatial resolution of the reviewed
HSI systems varies from recording only spread and feature-
less 2D responses in the brain (in the order of cm or mm) to
visualization of small details of the cerebral vasculature
(down to a few μm), mostly depending on the type of
detector, the FOV, the used reconstruction algorithm, as well
as the selection of the spectral bands.
Table 1 provides an overview of the representative HSI
systems that will be discussed in the next sections for imaging
and monitoring metabolic and hemodynamic activity of brain
tissue. Their characteristics are summarized, together with
their instrumentation, the image acquisition mode, the meta-
bolic parameters that they target and the triggering stimulus or
condition.
1.4. Measuring metabolic brain activity and hemodynamics
Functional metabolic activity in the brain can be generally
deﬁned as the sum of all the biochemical processes associated
with regular cerebral functions, including those that keep brain
cells alive and enable them to execute their biological roles in
the tissue. Even at rest, the metabolic energy demand of the
brain is considerable, being one of the highest energy-consum-
ing organs. It utilizes about 20%–23% of the total energy
requirement of the human adult body, despite representing only
2%–2.3% of its overall weight [56]. When the brain is subject to
metabolic activation due to signaling events stimulating cerebral
cells, an overall increase in ATP demand normally occurs. This
energy demand is higher than the typical ATP demand in the
basal resting state, which is set by the speciﬁc experimental
protocol used in the measurements. Thus, baseline metabolic
activity during rest condition usually varies depending on the
state of the subject, being for instance either awake, uncon-
scious, anesthetized or even comatose [34].
The detection and measurement of cerebral metabolic
signals through imaging enables to identify and localize
changes in brain activity and function under several condi-
tions: from resting state, through functional activation and
response to stimuli, to irregular physiological circumstances,
such as during tissue hypoxia, hyperoxia and even acute
ischemia. In particular, these abnormal conditions can disrupt
normal metabolism in deleterious ways, for instance due to
oxygen deﬁciency (in the cases of hypoxia and ischemia), and
subsequently lead to severe damages to cerebral tissues [57].
Different and interconnected energy-producing pathways
compose the overall metabolic activity of brain tissue: among
them, the two major ones are glycolysis and oxidative meta-
bolism, both cardinal in cellular respiration. Parameters rela-
ted to these processes and optical signals from compounds
directly involved in their key reactions, as either metabolites
or products, can be measured independently via HSI techni-
ques [34, 56, 58]. Figure 2 summarizes the main metabolic
pathways that can be targeted via HSI and the corresponding
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parameters and optical signals used to quantify brain meta-
bolic activity.
Glycolysis occurs in the cytosol of cells and, in aerobic
conditions, it converts glucose (C6H12O6) into pyruvate
(CH3COCOO
−). The free energy released by this process is
used to produce ATP and reduced nicotinamide adenine
dinucleotide (NADH). ATP is well known for being the
fundamental molecule involved in the storage and transport of
chemical energy within cells to fuel and drive their core
functions. NADH is another key coenzyme involved in the
oxidative metabolism that generally follows glycolysis, acting
as an electron donor in the electron transport chain
(ETC). NADH and pyruvate are then transferred inside the
mitochondria, where oxidative metabolism takes place
[34, 58–60].
During oxidative metabolism, pyruvate is ﬁrst converted
into acetyl-CoA inside the mitochondrial matrix, creating also
additional NADH and carbon dioxide (CO2) as a waste by-
product. Subsequently, acetyl-CoA is oxidized to CO2 in the
tricarboxylic acid (TCA) cycle, also called Krebs cycle, where
water is consumed and further ATP and NADH are produced.
In the TCA cycle, another important molecule is also gener-
ated, called reduced ﬂavin adenine dinucleotide (FADH2),
which like NADH it is utilized as a redox agent in the ﬁnal
stage of oxidative metabolism, called oxidative phosphor-
ylation. Oxidative phosphorylation occurs in the inner mem-
brane of the mitochondria and primarily involves a series of
redox reactions ultimately releasing chemical energy used to
synthetize additional ATP. These redox reactions are medi-
ated by four protein complexes linked together to form the
Figure 2. Diagram of the major metabolic pathways in brain tissue. Key metabolites and processes are reported, and related optical signals
and parameters (in green squares) can be measured and estimated using different HSI approaches: namely, quantiﬁcation of CMRO2,
detection of ﬂuorescence from NADH and FAD, plus monitoring of the redox states of CCO.
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ETC. NADH and FADH2, produced in the early phases,
initiate such process by donating electrons and converting
into their corresponding oxidized forms, i.e. NAD and FAD,
respectively. The electrons are then transferred through each
of the ETC complexes. Oxygen (O2), carried by hemoglobin
in the blood, diffuses into brain cells and receives the trans-
ported electrons via complex IV (also known as cytochrome-
c-oxidase, CCO) in the ETC, converting O2 into water and
CO2. Finally, the redox potential change in the ETC drives
the production of ATP through another large enzyme com-
plex, called ATP synthase [58–60].
It is evident that oxygen plays a crucial role in oxidative
metabolism, being the ultimate electron acceptor leading to
energy production and thus it is a key component, together
with glucose, for fueling the entire metabolic activity of brain
tissue. Moreover, the net amount of ATP produced during
oxidative phosphorylation, equal to about 30–32 molecules,
greatly surpasses that generated via glycolysis and all other
metabolic pathways, which total around ﬁve units [34].
Hence, mapping oxygen delivery and consumption across
regions of the brain is one of the ways to directly measure and
quantify brain metabolism. Nonetheless, monitoring just the
changes in concentrations of the two states of hemoglobin, i.e.
oxygenated (HbO2) and deoxygenated (HHb), in a speciﬁc
area of the brain does not explicitly assess O2 consumption in
metabolism. It is an index of oxygen demand and delivery to
brain tissue during rest conditions and under functional acti-
vation [61]. Brain oxygenation and hemodynamics mapping
is also fundamental to evaluate brain operation during oxy-
gen-dependent conditions, such as hypoxia, hyperoxia and
ischemia [62]. Functional magnetic resonance imaging
(fMRI) and functional NIR spectroscopy (fNIRS) are the
major modalities that have been used to achieve this purpose
[63–65]. In particular, HSI for brain oxygenation has relied on
approaches and methodologies similar to those used in
fNIRS, which will be largely discussed in section 2.
The principal parameter that is utilized to quantify cere-
bral oxidative metabolism is CMRO2. CMRO2 is the rate of
oxygen consumption by the brain and it is strongly related to
the cerebral blood ﬂow (CBF) [34, 66]. It can be measured
directly in vivo using positron emission tomography, by
imaging the uptake of radiolabelled 15O compounds [67].
However, indirect assessments of CMRO2 from hemody-
namic parameters have also been proposed and investigated
via fMRI [68] and fNIRS [69]. Section 3 will describe
extensively how HSI has been applied so far to estimate
CMRO2 from measurements of CBF and other hemodynamic
parameters.
Finally, optical imaging techniques have the capability of
assessing cellular energetics and ATP production in vivo
during brain metabolic activity, thanks to the light-dependent
properties of some of the molecules that are actively involved
in these processes. In particular, both FAD and NADH are
autoﬂuorescent in the visible range. Thus, by exciting these
compounds in brain tissue with speciﬁc wavelengths and
measuring the intensity of the emitted ﬂuorescence, it is
possible to quantify changes in their redox states, which
consequently indicate variations in the rate of production of
ATP during metabolism [70–72]. FAD and NADH have also
been targeted by HSI systems, taking advantage of their
superior spectral resolution and high number of wavelength
bands to simultaneously resolve their corresponding ﬂuor-
escent signals. These approaches can thus provide a new way
to assess brain metabolism. This will be discussed in
section 4.
Fluorescent exogenous analogs of key molecules
involved in cellular metabolic production of energy could also
be employed together with HSI techniques: this will also be
brieﬂy mentioned in section 4, although without being
extensively discussed in this article.
Similarly, the difference in the absorption spectra of the
reduced and oxidized states of CCO can be used to measure
its in vivo concentration. As seen previously, its redox states
are associated with O2 reduction and consumption in oxida-
tive metabolism. Therefore, monitoring and localizing CCO
in cerebral tissue can potentially provide another marker to
quantify brain metabolic activity. Studies will be reported in
section 4, on the use of broadband fNIRS to measure CCO
during brain functional activation and under hypoxic condi-
tions [60, 73]. Section 4 will also cover the feasibility and
proposals of applications of HSI to target and image CCO, as
a possible future solution for quantifying oxidative metabo-
lism in the brain.
2. HSI of brain tissue oxygenation during metabolic
activity changes
So far in the literature, the use of HSI to map localized
changes in oxygenation of various regions of the brain is the
most reported application of this optical technology to cere-
bral tissue metabolic and hemodynamic monitoring. The
in vivo measurement of the intrinsic contrast provided by
HbO2 and HHb has been an established pillar of fNIRS and
diffuse optical imaging (DOI) since its ﬁrst demonstration by
Jöbsis in the 1970s [64, 73], due to the distinctive absorption
spectra of these two chromophores (see ﬁgure 3) and the
advantage of the optical window (as mentioned earlier).
The two states of hemoglobin are the major absorbing
substances in the brain in the visible and NIR regions.
Therefore, changes in their relative concentrations can be
resolved by measuring variations in the absorption of brain
tissue during oxygenation and perfusion. The use of multiple
wavelengths between 400 and 1000 nm permit to obtain
superior sensitivity to these changes and better discrimination
between HbO2 and HHb [7, 49, 52]. For this reason, the
higher spectral resolution and narrower bandwidth of HSI
technologies are suitable for this task, having the potential to
acquire more precise and exhaustive spectral information of
the two compounds.
As mentioned before, mapping brain tissue oxygenation
does not provide direct quantitative measurements of brain
metabolism; nevertheless, it is still a signiﬁcant indicator of
brain metabolic activation. Functional activation in the brain
results in local variations of blood ﬂow, blood volume and
oxygen delivery and consumption, in order to fuel the
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increased neural activity [76–78]. A typical cortical response
to a stimulus involves an increase in the local concentration of
HbO2, due to increased oxygen supply, along with a reduction
in HHb [77, 78]. The total concentration of hemoglobin
(HbT), given by the sum of the concentrations of HbO2 and
HHb, also shows an increase, although smaller than that in
HbO2. The concentration of HbT can be derived from the sum
of the measured concentrations of HbO2 and HHb, or via a
direct measurement through the selection of wavelength
bands corresponding to the isobestic points of the absorption
spectra of the two chromophores (at around 500, 529, 570 and
798 nm) [31]. The overall timing of the hemodynamic
response generally varies according to different parameters,
such as the speciﬁc region of the brain cortex involved, the
type of triggering stimulus, the physiological conditions of
the subject (e.g. blood pressure), as well as the particular state
of hemoglobin considered. Nonetheless, the whole reaction
has a typical duration in the order of seconds to tens of sec-
onds, with a delay usually between the beginning of the sti-
mulus and the peak of the hemodynamic changes [31, 78].
The hemodynamic response of brain tissue to altered
oxygenation conditions, such as hypoxia, hyperoxia and
ischemia, is more complicated and heterogeneous than the
response to functional activation, due to the occurrence of
larger systemic and physiological effects. Examples of these
effects are variations in respiratory rate, ventilation and heart
rate [79]. The magnitude and timing of the hemodynamic
response are also dependent on the magnitude of the reduced
(or augmented) oxygenation, reaching maximum severity in
cases of acute ischemia and anoxia. In controlled exper-
imental protocols, the amount of oxygenation is normally set
by the fraction of inspired oxygen (FiO2). Again, it is possible
to identify a common and established trend for the changes in
concentrations of the two states of hemoglobin.
Typically, transient hypoxia induces a progressive
decrease in HbO2 and increase in HHb, which become more
severe as FiO2 is reduced. Both HbO2 and HHb eventually
tend to plateaus as the hypoxic condition is maintained with
time. HbT also usually shows a general rise, due to vascular
dilatation and increase in heart rate [60, 79, 80]. In ischemia,
which is typically induced by surgically blocking major brain
vasculature, the trend is equivalent to that of hypoxia but with
larger spatial extent and higher magnitude in the variations of
HbO2 and HHb, as well as signiﬁcant drop in HbT [57].
Conversely, a reverse situation can be observed in the case of
hyperoxia, where HbO2 increases and HHb diminishes with a
similar slow tendency to stable new levels. The incremented
oxygen supply also results in an increase in HbT due to the
larger concentration of oxygen in the blood [81, 82].
The majority of the HSI methodologies used to calculate
the changes in the concentrations of HbO2 and HHb from
measurement of light attenuation (in each pixel of the
hyperspectral images) are based on the modiﬁed Beer–Lam-
bert law (MBLL), developed by Delpy et al [83]. The MBLL
correlates the attenuation A of light intensity through brain
tissue at a speciﬁc time t and wavelength λ with the con-
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where I is the detected intensity, I0 is the incident intensity in
the tissue area, εi is the molar extinction coefﬁcient of the ith
chromophore, ci is the concentration of the ith chromophore
and G is a geometrical factor assessing scattering-related loss
of light intensity in the brain. The differential optical path-
length Da(λ) accounts for the wavelength-dependent incre-
ment in the distance traveled by the photons in the tissue due
to multiple scattering. Therefore, it represents the ‘true’
optical pathlength effectively covered by the light in the
cerebral tissue, which is can be also indicated as PL [84, 85].
The application of the MBLL to measured intensity
spectra does not normally permit to calculate absolute con-
centrations, but only relative temporal changes Δci in con-
centrations during a speciﬁc time interval Δt between a
speciﬁc time point t1 and an initial time t0, usually corresp-
onding to the basal rest condition. In this way, by looking at
the variation in ΔA in Δt, it is assumed that the change in the
scattering properties of brain tissue is small compared to the
Figure 3. Molar extinction spectra of HbO2 (solid) and HHb (dashed) in the visible (left) and NIR range (right). The values are taken from
Scott Prahl [74] for the visible range and from UCL Biomedical Optics Research Laboratory (BORL) database [75] for the NIR range.
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change in absorption due to the considered chromophores; it
is also assumed that the incident light intensity I0 is stationary
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Applying the previous equation (2) to the case of HbO2
and HHb and extending it to an arbitrary number M of
wavelength bands λn (according to the HSI setup), a system
of M linear equations can be obtained. The system can be
solved for the temporal changes of concentrations Δ[HbO2]x,y
and Δ[HHb]x,y in each pixel (x, y) of the acquired hyper-
spectral images, provided that the molar extinction coefﬁ-
cients nHbO ,2e l and εHHb,λn of the two chromophores at each
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Accurate estimates of the differential optical pathlength
Da(λn) at each wavelength are necessary in order to calculate
the relative changes in the concentrations of HbO2 and HHb.
In fNIRS, direct assessments of this optical pathlength can be
performed by measuring the time-of-ﬂight of photons in the
targeted tissue area [83]: such approach is advantageous for
this acquisition conﬁguration, involving the detection of dif-
fused NIR light and relatively large source-to-detector dis-
tances (normally few cm). However, for HSI applications that
normally measure reﬂected photons consisting also of visible
light, the optical pathlength is generally very small
(∼1–2 mm), thus the temporal resolution requirements to
measure the time-of-ﬂight are more difﬁcult to achieve.
Therefore, indirect estimations of Da(λn) are largely derived
from numerical analysis based on the diffusion theory and on
Monte Carlo simulations [85]. Furthermore, HSI requires the
2D distribution of the source illumination on the imaged area
to be taken into account for a correct evaluation of the optical
pathlengths in reﬂectance mode imaging.
HSI systems using the MBLL have been mostly used to
monitor hemodynamics response in brain tissue during
metabolic activation by targeting in vivo the exposed cortex of
animal subjects, especially rodents and cats [86–91]. Malonek
et al [87] implemented one of the ﬁrst applications of linear
scanning HSI to functional brain mapping, by targeting the
exposed visual cortex of an anesthetized cat with visible light
in the range 500–700 nm and spectral resolution spanning
between 1 and 4 nm. The HSI system used a slit and a dis-
persing grating assembly to acquire sequential spatio-spectral
images and reﬂection spectra of brain microcirculation and
hemoglobin response to variable visual stimulation. This
showed highly localized hemodynamic responses to the sti-
mulus in speciﬁc cortical regions within the ﬁrst 3 s, with
concentration changes spreading to larger distances of several
millimetres in the later phase of metabolic activation.
Similarly, Devor et al [89] investigated the hemodynamic
response of the brain to functional activation, as well as the
coupling between neural activity and blood oxygenation
during metabolic activity changes. For this purpose, a spectral
scanning imaging system was tested on the exposed soma-
tosensory cortex of rats during whisker stimulation. The setup
was composed of a mercury xenon arc lamp ﬁltered with a
6-position rotating ﬁlter wheel and it employed just six con-
tiguous wavelengths (560, 570, 580, 590, 600 and 610 nm) at
a switching rate of about 3 Hz. Each spectral image was then
acquired sequentially using a cooled 12-bit CCD camera.
Calculations of the variations in HbO2 and HHb were per-
formed using the MBLL and expressed in percentage change
maps relative to baseline concentrations of 60 and 40 μM,
respectively; while changes in HbT were obtained as the sum
of the values of the previous two chromophores. The differ-
ential optical pathlength at each wavelength was estimated
using Monte Carlo simulations based on Kohl et al [85]. The
calculated oxygenation change maps, showed in ﬁgure 4,
spatially localized an initial increase in HHb, but also reported
an equivalent rapid decrease in HbO2 that balanced such
effect, leading to a stationary level of HbT during the initial
phase after the stimulus. These hemodynamic results were
then compared to simultaneous electrophysiological record-
ings in the same region of the brain using metallic electrodes,
which quantiﬁed synaptic electrical activity: the comparison
between these two different signals indicated a nonlinear and
unsynchronized relationship between the neural activation
and the hemodynamic response.
A critical factor to be considered in HSI of the exposed
cortex is the depth of penetration traveled by the detected
light in the brain tissue. Since this reﬂected light usually has
penetrated few millimetres in the cortex, the overall measured
signal results to be composed of weighted contributions
belonging to various layers of cerebral tissue (i.e. surface of
the cortex and parenchyma), where optical properties and
vasculature structure differ. Therefore, this generates a difﬁ-
culty in localizing precisely the depth in the cerebral cortex at
which the hemodynamic response occurs. The problem is
further complicated by the fact that the penetration depth is
also wavelength-dependent, since photons at different wave-
lengths experience different optical pathlengths in the same
brain region.
A recent work by Konecky et al [91] tried to assess the
issue of depth sensitivity by using a diffuse optical tomo-
graphy (DOT) approach to HSI of rat somatosensory cortex
under single whisker stimulation. They developed a snapshot
HSI system [92] using 38 spectral bands from 484 to 652 nm
at an image rate of 5 Hz. The spectral resolution of the system
varied from 3 to 8 nm, while the imaged FOV was 6×6 mm.
In addition to the application of the MBLL to calculate
changes in HbO2 and HHb, they also implemented the Rytov
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approximation [93], typical of DOT image reconstruction,
analyzing the depth-dependent distortion of the reﬂectance
spectra in order to localize the hemoglobin variations at
various depths in the brain tissue. The results of the invest-
igation reported a peak in the hemodynamic response after 3 s
post-stimulus using the MBLL, while the Rytov approx-
imation estimated a longer time to peak of about 4 s. The
magnitude of the concentration changes calculated with the
Rytov tomographic reconstruction were also larger than those
obtained by the MBLL, due to the partial volumetric effects
the Rytov approximation accounted for. The DOT-based
approach was also able to localize the maximum of the
hemodynamic response at less than a millimetre beneath the
surface of the cortex (precisely, 0.29±0.02 mm for HbO2
and 0.66±0.04 mm for HHb). The conﬁguration of the HSI
system and part of the results of the study are shown in
ﬁgure 5. The difference in the depth at which the maximum
variations in HbO2 and HHb occurred during functional
activation may be attributed to a rapid depletion of oxygen in
the superﬁcial cortex, followed by a reperfusion of oxyge-
nated blood in the same region. It could also be related to the
different distribution of arterioles and venules in brain tissue
layers, although the authors also suggested a potential tech-
nical limitation of the system to fully resolve the depth of the
two chromophores.
The targeting of the exposed cortex of small animals
using HSI has also been a preferential choice in several stu-
dies assessing hemodynamic response and brain tissue oxy-
genation during induced hypoxia and hyperoxia [94–97].
Shonat et al [94] were among the ﬁrst to use HSI with AOTFs
to study the hemodynamic variations in the exposed cortex of
mice under different FiO2 levels, from normoxia (FiO2=
21%), through moderate hyperoxia (FiO2=60%), to hypoxia
(FiO2=10%). The AOTFs permitted a rapid sequential
acquisition of 12 wavelengths from 504 to 600 nm (5 nm
bandwidth and 8 nm increments) by ﬁltering the reﬂected
light before detection using a slow-scan CCD camera. The
reﬂectance spectra were then used to calculate changes in
HbO2 and HHb using the MBLL and from these, hemoglobin
saturation (SO2) maps were derived. The results of these SO2
maps were ultimately compared with oxygen tension (PO2)
maps obtained simultaneously via phosphorescence lifetime
imaging: the magnitude of the expected increase in SO2 (as
tissue oxygenation was varied from hypoxia, through nor-
moxia, to ﬁnally hyperoxia) was found to match that of PO2,
except for the ﬁnal increment in SO2 during hyperoxia. This
did not mirror the larger change of PO2, possibly indicating
that hemoglobin was close to saturation in that condition.
HSI imaging of brain tissue hemodynamics during neural
activation has not been only conﬁned to small animal ima-
ging. Several attempts to apply hyperspectral approaches to
the human exposed cortex are present in the literature, pri-
marily during epilepsy surgery [98–100]. Pichette et al [98]
recently tested a proof-of-concept snapshot HSI system
combining a neurosurgical microscope with a commercial
hyperspectral camera for simultaneous detection of 16 spec-
tral bands ranging from 481 to 632 nm, with spectral reso-
lution of about 15 nm (FWHM). This setup was utilized on a
Figure 4. HbO2, HHb and HbT spatio-temporal mapping in the exposed somatosensory cortex during tactile stimulation. Each hyperspectral
frame was acquired every 200 ms (series (B) is a continuation of (A)), with the black scale bar set at 500 μm. The changes in concentrations
are expressed as percentage variations respect to baseline (60 and 40 μM, for HbO2 and HHb respectively). Reprinted from [89], Copyright
(2003), with permission from Elsevier.
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fully exposed adult cortex before epileptogenic tissue resec-
tion, at a frame rate of 20 fps and acquisition time of 40 ms
per frame. The resulting changes in concentrations of HbO2,
HHb and HbT were calculated using the MBLL, together with
a spectral unmixing algorithm, and provided hemodynamic
monitoring of the resting metabolic state of human brain
(ﬁgure 6). Small changes in the hemodynamic response
compared to the baseline were attributed to a mix of Mayer
waves, vasomotion and epileptic spikes.
Before concluding this section, it must be noted that
using MBLL to map hemodynamic changes during brain
metabolic activation is not the only approach to hyperspectral
data processing that has been investigated. Multivariate ana-
lysis algorithms, such as principal component analysis
[101, 102] and independent component analysis [103], have
also been implemented to hyperspectral images of brain
hemodynamics, primarily to reduce the large amount of
information that HSI provides. These types of statistical-
Figure 5. (A) Snapshot HSI setup used to image rat somatosensory expose cortex at 38 spectral bands during a single 50 ms exposure. The
2D images for each wavelength were obtained using mapping reconstruction from dispersed light though a prism array. (B) The changes in
concentration of HbO2 and HHb were reconstructed using a Rytov tomographic algorithm to generate cross-sections of the hemodynamic
response at different depths z in brain tissue after 4 s post-stimulus. Reproduced with permission from [91].
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based analyses are more technically familiar to applications of
HSI in various ﬁelds outside biomedical applications [104].
3. Assessment of CMRO2 using HSI
2D hyperspectral measurement of brain hemodynamic
response under metabolic activation (as discussed in the
previous section) provides high-resolution visual information
about the current oxygenation states of different cerebral
regions, but fundamentally lacks the capability to quantify
oxidative metabolism. Hyperspectral spatial mapping of
changes in the concentrations of HbO2, HHb and HbT only
assesses the distribution of oxygen in the brain at speciﬁc time
frames, without determining the rate at which O2 is effec-
tively consumed in cerebral metabolism and also the rate at
which it is consequently replaced to maintain continuous
fueling of neural activity. CMRO2 is the hemodynamic and
metabolic parameter that accounts for brain oxygen con-
sumption and its calculation requires the measurement of the
CBF, to quantify the amount of O2 that is transported into and
out of speciﬁc activated brain regions over time. A 2D
mapping of CMRO2 thus represents a direct measure of cer-
ebral oxidative metabolism and its variations under different
circumstances, due to the targeting of molecular oxygen as an
essential key element.
CMRO2 is generally deﬁned as the product of CBF and
the cerebral oxygen extraction factor, which is given by the
net difference between cerebral arterial oxygen saturation
(SaO2) and cerebral venous oxygen saturation (SvO2):
CMRO CBF SaO SvO . 42 2 2= ⋅ -( ) ( )
Both SaO2 and SvO2 depend on the measurement of
other cerebral hemodynamic parameters, i.e. the concentra-
tions of HbO2, HHb and HbT. Several models have been
proposed over the years to express the correlation between
CMRO2, hemodynamic parameters and CBF [105–107]. A
general equation to derive the relative change ΔCMRO2
respect with a baseline CMRO2 was ﬁrst established by
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In equation (5), [HHb]v and [HbT]v are the baseline
concentrations of HHb and HbT in the localized brain venous
compartment, while Δ[HHb]v and Δ[HbT]v are the corresp-
onding time-dependent changes after metabolic activation
(typically measured in μM). Similarly, CBF and ΔCBF
represent the baseline value of the CBF and its post-activation
change (generally in mmmin–1), respectively. Assuming that
the hemoglobin concentration changes in the venous com-
partment are proportional to those across all the brain vas-
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where γr and γt are factors correlating the hemoglobin base-
lines ([HHb]v and [HbT]v) and the hemoglobin changes
Figure 6. In vivo intraoperative HSI of the hemodynamic response in human exposed cortex: the top-left image shows the RGB image of the
cortex, while the remaining pictures present the maps of the calculated relative changes in the concentrations of HbO2, HHb and HbT
(clockwise from top-right). Contrast outside the major vessels (dark areas) was enhanced in order to highlight the small oxygenation changes
in the capillary regions. The gray areas correspond to eliminated saturated regions of pixels, due to specular reﬂection. Reproduced with
permission from [98].
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(Δ[HHb]v and Δ[HbT]v) in the venous compartments with
the corresponding baselines ([HHb] and [HbT]) and changes














































As seen in the previous section, HSI systems are able to
efﬁciently measure Δ[HHb] and Δ[HbT], yet they cannot
provide direct quantiﬁcation of CBF and its dynamic changes
in response to brain metabolic demand. Therefore, combina-
tions of HSI with other ﬂowmetric imaging modalities cap-
able of measuring in vivo CBF have been tested and
investigated, to simultaneously acquire data of all the relevant
quantities necessary for calculating CMRO2 using
equation (6), thus assessing oxidative metabolism during
brain activation [88, 109–112]. Laser speckle contrast ima-
ging [113] is one of the most suitable techniques to imple-
ment in a single system together with HSI. It takes advantage
of the speckle random interference produced by laser light
after it is scattered by brain tissue. 2D detection of this
scattered light produces images characterized by a granulose-
looking pattern, known as image speckle. When the scattering
of the laser light is caused by moving red blood cells, then the
image speckle ﬂuctuates between images acquired over time.
Hence, the rate of variation of the speckle pattern can be
mathematically correlated with the time-varying velocity of
the red blood cells in each pixel, which can be used to spa-
tially resolve and quantify CBF at speciﬁc time points [114].
Dunn et al [88] proposed an integrated system combining
laser speckle contrast imaging with the six-wavelength HSI
setup that was previously described in section 2 and used to
calculate metabolic-related hemodynamic changes in the
exposed cortex [89]. In addition to the ﬁltered illumination at
560, 570, 580, 590, 600 and 610 nm, they used an expanded
laser diode to illuminate the exposed cortex of mice at
785 nm, in order to generate the image speckle. In earlier
studies [88, 109], the speckle contrast images were acquired
with the same CCD camera utilized to collect also the
hyperspectral intrinsic signal from HbO2 and HHb. With this
conﬁguration, the imaging system was repeatedly used to
image the exposed somatosensory cortex of a mouse during
tactile stimulations (either forepaw or whiskers). In the ﬁrst of
these studies [88], only maps of the fractional changes in
HbO2, HHb and CBF were calculated, as the ratio between
the responses integrated over 3–4 s after the stimulus and the
corresponding pre-stimulus baselines. As depicted in
ﬁgure 7(a), the HSI-derived images localized the area of the
cortex associated with the maximum rises in HbO2 and CBF,
although the peak of the latter covers a larger, more spread
and less deﬁned region. CMRO2 was calculated using
equation (6), assuming unitary values for γr and γt. Its aver-
age temporal evolution over the activated area for all the
duration of the stimulus was found to follow a similar trend to
the hemodynamic response of HbO2. The same resulted for
the time-variation of CBF, even though its response was
found to be about three times greater than that of CMRO2.
In the second investigation with the same system [109],
the spatial localization and extent of the changes in CMRO2
were mapped as well (ﬁgure 7(b)), and then compared with
the other parameters, in order to relate metabolic and hemo-
dynamic responses in the brain during functional activation.
The peak responses of CMRO2, hemoglobin and CBF all
showed a similar distribution in the same activated region,
with CMRO2 covering a slightly larger area only in the pre-
liminary phases of the stimulus onset. However, as in the
previous investigation, the ratio ΔCBF/ΔCMRO2, indicating
blood ﬂow consumption by metabolism, was found to be
equal to 1.5 and 2 for the peak responses to whiskers and
forepaw stimulation, respectively. The authors suggested that
this discrepancy in the responses of CBF and CMRO2 sup-
ported the hypothesis of an uncoupling between cerebral
oxidative metabolism and brain hemodynamics during acti-
vation. Additionally, in contrast with the ﬁrst study, the
temporal trends of the percentage changes in CBF and
CMRO2 showed a prolonged plateau after the peak of their
respective responses.
An important question which was also targeted by the
second study using the system of Dunn et al [109] regards the
dependency of the estimated CMRO2 on the assumed values
of γr and γt. The effects of these vascular weighting constants
on the spatial extent of the metabolic and hemodynamic
quantities were then evaluated by varying both γr and γt from
0.5 to 2, which represents the expected physiological range of
these two factors [108]. Consequently, only a small percent-
age change in the spatial extent of the CMRO2 response was
estimated across the range of the γ factors compared to the
unitary assumption (γr =γt =1), thus implying a limited
inﬂuence of the assumed vascular compartmentalization on
the assessments of the cerebral oxidative metabolism.
A second version of the aforementioned system was later
developed and included a secondary CCD camera for separate
acquisition of the laser speckle images. This new setup was
then applied to image and monitor the metabolic and hemo-
dynamic states of the exposed cortex of a mouse during
induced focal cerebral ischemia [110]. This condition resulted
in much larger relative variations in both CBF and in the
concentrations of HbO2 and HHb, compared to those asso-
ciated with functional activation; thus, a ﬁrst-order linear
approximation of the nonlinear system derived from the
MBLL (see equation (3)) was found to lead to signiﬁcant
errors in the calculations of the hemodynamic response. The
results of the MBLL were compared with numerical simula-
tions to account for the large increase of the optical path-
lengths (more than 60%) in the ischemic core, in comparison
with their corresponding baseline values. Overestimation of
the decrease in the concentration of HbO2 during the acute
ischemic-hypoxia was demonstrated with the MBLL, com-
pared to the numerically predicted changes. Contrarily, a
nonlinear ﬁtting algorithm minimizing the difference between
the measured light reﬂectance and that predicted through a
perturbation Monte Carlo model showed better accuracy and
consistency with the simulated results. Subsequently, larger
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drops in HbO2, CBF and CMRO2 were localized in the
ischemic core right after the onset of the acute hypoxic con-
ditions, while HHb increased as expected. A further reduction
in all the hemodynamic quantities and in cerebral oxidative
metabolism was also reported, spreading ﬁrst to the ischemic
penumbra and then to the non-ischemic areas. Persistent
reduction in CMRO2 progressed as ischemia was maintained,
even in areas unaffected by direct hypoxia. However, small
Figure 7. (A) Fractional change maps of HbO2 (a), HHb (b) and CBF (c), obtained after HSI of the exposed cortex of a mouse during single
whisker stimulation. Scale bar (in black) equal to 0.5 mm. The temporal trends of the responses of HbO2, HHb, HbT, CBF and CMRO2
(d) are also shown as averaged values over the activation area. Reproduced with permission from [88], Optical Society of America. (B)
Spatial extent of HbO2, HHb, HbT, CBF and CMRO2 superimposed on an image of the exposed cortex of a mouse during forepaw
stimulation. The responses have been averaged around their peaking times and thresholded at 1/3 of their maximum values (A=anterior,
L=lateral, scale bar=1 mm). Reprinted from [109], Copyright (2005), with permission from Elsevier.
15
J. Opt. 20 (2018) 044009 Review
residuals of metabolic activity were found to persist across the
image cortex. The removal of the hypoxic conditions,
allowing brain tissue reperfusion, resulted in a recovery of all
the metabolic and hemodynamic parameters, although not
back to pre-ischemia levels. Calculated CMRO2 values after
reperfusion remained below those of the baseline before the
hypoxic onset, thus implying a possible irreversible sup-
pression of the metabolic activity of the affected brain tissue.
In conclusion to this section, it is worth to mention a
methodology proposed by Boas et al [69] for indirectly
estimating the variation of CMRO2 during metabolic activa-
tion using only measured changes in HbO2 and HHb derived
from optical data, i.e. without the need of CBF measurements.
This approach is based on the Windkessel model [115] that
relates changes in CBF to changes in cerebral blood volume
(CBV). From the model, it is then possible to estimate the
CBF response following brain activation from optical mea-
surements of the changes in the concentration of HbT and
under the assumption that during the hemodynamic response:
Δ[HbT]/[HbT]=ΔCBV/CBV. The approach was applied
and validated using human fNIRS data measured at two
wavelengths (682 and 830 nm) during motor stimulation.
Although the methodology was shown to produced estimates
of CMRO2 in the same range of parallel experimental ﬁndings
in the literature, it also seemed to be affected by some lim-
itations in its accuracy. In particular, the optical approach was
unable to discriminate between a tight coupling of the var-
iations of CMRO2 with changes in CBF and null changes in
CMRO2 during the metabolic activation. Therefore, the
authors recommended better information concerning the
relationship between cerebral ﬂow and volume in order to
address these issues. Anyway, no applications of the afore-
mentioned method to HSI have been found so far in the
literature.
4. HSI of cerebral cellular energetics: a future
perspective
An alternative approach to hyperspectral in vivo monitoring
of brain metabolic activity and function focuses on measuring
mitochondrial energetics and ATP production in the neurons
directly. Instead of targeting hemodynamics parameters, such
as the different states of hemoglobin and the CBF, the optical
properties of different compounds involved in neuronal
energy production can be exploited, in order to assess and
quantify metabolism by measuring the changes in the redox
states of these molecules during cellular respiration.
From the analysis of the existing literature, it has
emerged that HSI of cellular metabolites is not as widespread
as the previously discussed approaches. Nonetheless, it has
the unique capability to provide a speciﬁc insight to the
molecular processes on which the cerebral metabolic activity
is based and by which it is fundamentally driven. Thus, it can
be seen as a future promising direction in the application of
biomedical hyperspectral monitoring to the metabolism of the
living brain, particularly if coupled with the complementary
information provided by the simultaneous imaging of cerebral
hemodynamics and tissue oxygenation.
Fluorescent endogens such as FAD and NADH have
been imaged through hyperspectral methods, yet with very
few in vivo applications and none on the living brain.
Nonetheless, HSI setups explicitly targeting ﬂuorescence
have been presented and tested, showing the capability of
simultaneous imaging multiple endogenous ﬂuorophores.
This opens to the potential implementation of this metho-
dology for cerebral metabolic monitoring.
In addition to endogenous ﬂuorophores, HSI could also
be potentially applied to target ﬂuorescence signals from
exogenous substitutes of important compounds involved in
cellular energetics. Among these, one of the most promising
could be 2-NBDG, a ﬂuorescent analog of deoxyglucose with
emission around 550 nm, when excited at 475 nm [116]. This
compound has been used to monitor in vivo cerebral glucose
uptake in the brain [117]. However, to our knowledge, no
applications of HSI to 2-NBDG ﬂuorescence have been found
in the literature.
Similarly, the quantiﬁcation of CCO in vivo has been
largely demonstrated only through broadband spectroscopy
and fNIRS techniques. The transition from broadband point-
spatial approaches to 2D HSI for directly imaging the changes
in the redox states of CCO is proposed here as a potential new
solution for monitoring brain metabolism.
4.1. Fluorescence HSI of FAD and NADH
Flavoproteins (FAD/FADH2) and NADH represent the most
targeted intrinsic biomarkers of mitochondrial metabolism in
the brain cortex, due to their autoﬂuorescence properties. The
reduced form of NADH shows maximum light absorption in
the range 320–380 nm, peaking at 365 nm, and it emits
ﬂuorescent light between 420 and 480 nm, with a maximum
centered at 450 nm [72, 118]. Since its oxidized form, NAD
(also known as NAD+), provides a negligible contribution to
light absorption in the aforementioned range, it is possible to
selectively excite NADH with UV light and detects its
ﬂuorescent emission [70]. Variations in the intensity levels of
the detected ﬂuorescence indicate changes in the concentra-
tion of the reduced state NADH associated with the rate of
production of ATP in the neuronal mitochondria. A reduction
in the detected ﬂuorescent emission is typically linked to a
decrease in the concentration of NADH due to its oxidation in
the ETC, after cerebral metabolic activation that leads to
higher energy demand by the brain. It has been demonstrated
that the contribution to the ﬂuorescence signal of mitochon-
drial NADH is 6–8 times greater than that of NADH in
cytoplasm, thus connecting NADH ﬂuorescence directly to
the process of ATP synthesis [119]. During hypoxic condi-
tions, NADH ﬂuorescence and concentration increase,
reaching a maximum level under complete oxygen depriva-
tion and acute ischemia when oxidative phosphorylation is
largely suppressed. On the contrary, brain hyperoxia produces
a decrease in NADH due to increased oxygen supply, in the
same way as during functional activation [118].
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Similar to NADH, FADH2 is also actively involved in
mitochondrial energetics as an electron donor in the ETC.
However, it is its oxidized form, FAD, that exhibits ﬂuores-
cence properties with emission in the range 500–560 nm,
peaking at around 520 nm, while its absorption spectrum
reveals two prominent bands for excitation: one between 320
and 390 nm, the other between 430 and 500 nm (the latter is
the most exploited) [72, 120]. The response of FAD ﬂuor-
escence emission to functional activation has been demon-
strated to be biphasic [121–124]: a brief (1–2 s) increase in
ﬂuorescence intensity (light phase), corresponding to the
onset of the stimulus, is generally followed by a much slower
decrease in detected light (dark phase) within a few seconds
after the termination of the stimulus. In case of hypoxic
conditions, when metabolic activity reduces due to lack of
oxygen, relative changes in the FAD ﬂuorescence emission
become evident only after signiﬁcant deﬁciency of tissue
oxygenation (FiO210%), showing a decrease in the
ﬂuorescent signal [125].
Relative differences in the ﬂuorescence emission of FAD
and NADH compared to basal levels can then be imaged in
order to localize the sites of metabolic activation and quan-
titatively monitor mitochondrial energy production in the
brain. It has been found that the autoﬂuorescence signal is
substantially larger (10–100 times) than the intrinsic optical
signal associated with hemodynamics and tissue oxygenation.
The ﬂuorescence response also shows a faster temporal
course than the hemodynamic one [121, 123]. Moreover, the
signal strength and the spatial resolution of the hemodynamic
response typically vary across different regions of the brain
according to the density of the vascular bed in each area,
while the ﬂuorescence response can be used to speciﬁcally
identify metabolic changes with higher accuracy and inde-
pendently of vasculature distribution [123].
It is also possible to combine the information provided by
the two different ﬂuorescence signals of FAD and NADH by
simultaneous measurement: the ratio between the ﬂuores-
cence intensity of the oxidized FAD and the ﬂuorescence
intensity of the reduced NADH is commonly called ﬂuores-
cence redox ratio and provides assessment of the overall
oxidation–reduction state in the mitochondria during meta-
bolic activity. A reduction in such redox ratio commonly
indicates an increase in cellular metabolic rate in response to a
stimulus or during speciﬁc conditions [126, 127].
Fluorescence imaging of the living brain has been widely
investigated by measuring the integrated emission intensity
over relatively wide bandwidths, yet mostly without using
any spectral information regarding the detected light. None-
theless, applications of HSI to the detection of the ﬂuores-
cence signals emitted by FAD and NADH can provide
multiple advantages, by improving its quantitative accuracy
and potentially enabling image multiplexing, i.e. the simul-
taneous monitoring of both the two aforementioned molecules
and even of other chromophores (HbO2, HHb among others)
relevant to metabolism [128, 129]. Furthermore, analysis of
the ﬂuorescent spectra can be used for depth discrimination
and localization of the emitting sources [129].
In vitro and ex vivo studies have been performed using
HSI to target ﬂuorescent metabolites in brain cells and cere-
bral tissue [130–132], although in vivo brain functional stu-
dies have not been found in the current literature. Various
proposed HSI systems have been characterized for detection
of ﬂuorescence and have shown potential ﬁtness to target
multiple endogenous ﬂuorophores, such as FAD and NADH,
with high spatial and spectral resolution performances
[131–136]. For example, Gao et al [134] proposed a hyper-
spectral snapshot system for ﬂuorescence imaging, capable of
simultaneously acquiring 25 wavelength bands with 5.6 nm
spectral resolution and 0.45 μm spatial resolution. Snapshot
acquisition was obtained through the use of an image slicer
mirror assembly. The HSI system was tested on phantom
models containing ﬂuorescent beads of diameter equal to
around 2.5 μm and ﬂuorescence emission peaks centered at
520 nm, corresponding to the peak of FAD.
For future in vivo brain applications of HSI to FAD and
NADH ﬂuorescence detection, the exposed cortex of small
animals could be again the preferential target, since the near-
UV and visible range is involved in both the excitation and
the emission processes. However, the use of short-wavelength
illumination is also the source of one of the primary issues
concerning in vivo ﬂuorescence imaging of NADH and FAD:
in addition to the low penetration depth in the cortex, the use
of UV light below 400 nm (in the case of excitation of
NADH) can cause signiﬁcant damage to the illuminated tis-
sue. To overcome this problem, a combination of HSI with
another optical ﬂuorescence technique, called two-photon
ﬂuorescence imaging, may be advantageous [31, 137]. Two-
photon ﬂuorescence imaging is based on the use of high-
output pulsed lasers emitting NIR light: when a sufﬁciently
high photon ﬂux is achieved, it is possible that two of the
lower-energy NIR photons emitted in quick succession by the
laser are absorbed simultaneously by the targeted ﬂuorophore
via a nonlinear excitation process. Consequently, the com-
pound would emit ﬂuorescence as if it was excited in the
usual way. This technique allows NIR excitation of FAD and
NADH with higher tissue penetration and eliminating the use
of UV light [138]. Hyperspectral approaches to two-photon
ﬂuorescence imaging are currently being investigated [136,
139–141], opening up the possibility of moving such tech-
nology also towards in vivo measurements of brain
metabolism.
4.2. HSI of cytochrome-c-oxidase
When the use of NIR light for biomedical applications was ﬁrst
proposed by Jöbsis [73], the primary intention was to measure
in vivo tissue changes in the redox states of CCO, because of its
fundamental role in metabolism. Following that milestone
study, fNIRS technologies and methodologies have been used
to speciﬁcally exploit the absorption properties of this chro-
mophore, in order to quantify directly and non-invasively cer-
ebral metabolic activity in both small animals and humans.
Indeed, broadband NIRS has shown the capability to combine
information provided by CCO with the complementary and
more extensively investigated hemodynamic response (from the
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measurements of HbO2 and HHb) [60, 142]. In particular, CCO
is a suitable biomarker for functional imaging of the brain, since
its cerebral concentration is far higher than in other extra-
cerebral tissues [143].
The advantage of using the NIR window to target CCO
(speciﬁcally the optical signature of its copper CuA redox
center between 780 and 900 nm) derives from the character-
istics of the molar extinction spectra of its oxidized (oxCCO)
and reduced (redCCO) forms. The total concentration of this
chromophore does not vary signiﬁcantly over relatively short
periods of time (in the order of hours, thus much longer than
the typical time trends of cerebral metabolic activation); thus,
it has been demonstrated [60] that the difference absorption
spectrum between oxCCO and redCCO (ﬁgure 8), combined
with the measured changes in NIR light attenuation in brain
tissue, can provide direct information about the relative var-
iations in the CCO redox states in vivo. Particularly, con-







(λ), i.e. the oxi-
dized-reduced difference between the molar extinction coef-
ﬁcients of CCO (the opposite can be done for assessing
changes in redCCO). As for the hemodynamic response, the
same MBLL approach previously described by equation (3)
in section 2 can be implemented to calculate the relative
changes Δ[oxCCO] in the concentration of the oxidized
species of CCO, by simply adding it as a third chromophore
to the system of equations [60].
As described in section 1, the oxidation of CCO is
directly correlated to production of ATP during cellular
respiration. Therefore, variations in the concentration of
oxCCO indicate alterations of the rate of metabolic energy
production in the brain. An increase in the relative con-
centration of oxCCO typically corresponds to an increment in
cerebral metabolism, for instance during functional activation
[144–146]. Oxidation of CCO is also affected by brain oxy-
gen supply [147]: during hypoxic conditions, oxCCO
response generally presents a decrease in concentration
[79, 143, 148], while an increase is typically associated with
hyperoxia [149]. However, CCO is not tightly coupled with
hemodynamics, due to its speciﬁcity to cellular metabolism,
as well as its dependency on the availability of electrons for
the ETC [147].
Several challenges are associated with the differentiation
of the oxCCO signature from the hemoglobin signals, pri-
marily due to the lower concentration of CCO in the brain (as
well as in any other tissue, in general) compared to hemo-
globin. Even though this is partially compensated by its
higher absorption in the NIR region, the overall maximum
contribution of oxCCO to the measurable optical signal is
typically an order of magnitude lower than the contribution of
HbO2 and HHb [60]. As a result of this, it is difﬁcult to
separate the signal generated by CCO redox changes from
that related to the two hemoglobin species by just using few
selected wavelengths. However, it has been demonstrated
[150, 151] that the use of a high number of wavelengths
covering the entire range of the NIR peak of the difference
spectrum of CCO, from 780 to 900 nm (as seen in ﬁgure 8),
signiﬁcantly improves differentiation between the oxCCO
and hemoglobin optical signatures, as well as overall accuracy
and quality of the data.
Broadband NIR spectroscopy is currently used to moni-
tor in vivo brain metabolism via measurements of the con-
centration changes in HbO2, HHb and oxCCO, to achieve
quantiﬁcation of cerebral metabolic activation in different
situations, from functional stimulation to response during
oxygen-dependent conditions. Although NIRS analysis does
not provide direct imaging information, recent attempts to
spatially mapping brain metabolic activity have been pub-
lished, using multichannel broadband spectroscopy to topo-
graphically and even volumetrically resolve changes in CCO
and hemodynamics across different regions of the living
cerebral cortex [152, 153]. For instance, Brigadoi et al [153]
implemented a DOT approach to reconstruct the broadband
spectroscopic data measured at fourteen different spatial
locations in the left occipital cortex of human subjects during
visual stimulation. The measurements were accomplished
non-invasively via multiple-sources illumination of the head
with white light and detection of the attenuation spectra of the
diffused light. Seventeen discrete wavelengths from 740 to
900 nm at intervals of 10 nm were then chosen for the
reconstruction, to limit computational burden. Tomographical
maps were obtained for HbO2, HHb and oxCCO showing
their corresponding relative changes in concentration at dif-
ferent time points during and after the visual stimulus. As
reported in ﬁgure 9, the typical hemodynamic response to
functional activation was localized in the cortex, derived from
changes in HbO2 and HHb. The spatial and temporal variation
of oxCCO was found similar to that of HbO2, though with
lower magnitude in the concentration increase following the
stimulation.
The spatially-resolved spectroscopic approach of broad-
band fNIRS to the measurement of oxCCO as an indicator of
brain metabolism could be extended to 2D imaging and HSI
has the potential to be the best candidate for this. In this
perspective, HSI can be seen as the multidimensional
equivalent of broadband NIRS, where every pixel of the
image is associated with the corresponding spectral infor-
mation. The capability of HSI to utilize multiple narrow
Figure 8. Oxidized-reduced difference molar extinction spectrum of
CCO in the NIR range. The values are taken from UCL Biomedical
Optics Research Laboratory database [75].
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wavelength bands in the NIR range could be used to accu-
rately resolve the signal from oxCCO. From that, spatial
distribution of the changes in the concentration of oxCCO can
be monitored, thus providing a complete insight in the
metabolic activity of the brain. Moreover, thanks to the NIR
optical window in tissue and the smaller presence of CCO in
the scalp and skull, compared to the cerebral cortex, HSI
monitoring of brain metabolism could possibly be performed
also non-invasively in vivo on humans.
Currently, a single paper was found in the literature, by
Yin et al [95], presenting a hyperspectral approach to the
invasive imaging of CCO in the living brain, using visible
light instead of NIR, and by targeting the spectral signature of
its haem centers (collectively known as cytochrome aa3)
instead of CuA. The article reported a very comprehensive
study on the simultaneous HSI of hemodynamic response,
mitochondrial metabolism and scattering changes in the
exposed parietal cortex of rats during cortical spreading
depression (CSD), a particular condition likely to occur in the
brain following ischemia. The system used in the study was
composed of a white light source and CCD camera mounted
on a microscope, while LCTFs were employed to acquire
images at nine different wavelengths (450, 470, 500, 530,
550, 570, 600, 630 and 650 nm). Six signals were resolved in
the hyperspectral images, corresponding to the optical
absorption of HbO2, HHb (for hemodynamics), reduced CCO
(referred as Cytaa3-R in the article), FAD and reduced
cytochrome c (for metabolism), plus variations in light
scattering due to CSD. Cytochrome c is a chromophore that is
oxidized by CCO during the ETC. Each concentration change
was calculated using the MBLL with Monte Carlo estimations
of the differential pathlengths. The main purpose of the study
was to estimate the relative contributions of each of these
signals to the overall measured optical attenuation, in order to
evaluate accuracy in the quantiﬁcation of the hemodynamic
response during CSD. However, the study was able to provide
for the ﬁrst time (to our knowledge) spatial mapping of CCO
redox changes in the exposed cortex. This can be seen clearly
in ﬁgure 10. The absorption peaks of cytochrome aa3 in the
visible range, at about 444, 605 and 650 nm, were targeted by
the system, although such approach is more prone to noise
than using NIR light, due to the predominant inﬂuence of
hemoglobin in the extinction spectrum below 750 nm. Fur-
thermore, the ﬂuorescence emission of FAD was not
accounted for. The metabolic response associated with red-
CCO (which has an opposite trend to oxCCO) showed an
increase in its relative concentration followed by a smaller
decrease before returning to baseline, corresponding to a drop
in cerebral metabolism and subsequent recovery during and
after CSD. The peak of the response of redCCO was also
found to be almost synchronized with the hemodynamic
response, as well as with the maximum variations of the other
two metabolites and the scattering.
The application of HSI to metabolic monitoring of the
brain via measurement of the redox states of CCO may
represent a future direction in the use of this technology for
Figure 9. Volumetric reconstruction of spatially-resolved changes in the relative concentrations of HbO2 (ﬁrst row), HHb (second row) and
oxCCO (third row) in the left occipital cortex of human brain during visual stimulation. The temporal variations of both the hemodynamic
and metabolic responses were monitored at 2, 10, 20, 30 and 40 s after the stimulus. The data were obtained using broadband fNIRS at
multiple source-detector channels across the investigated brain region. Reproduced with permission from [153].
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imaging cerebral metabolism, especially non-invasively and
with the possibility to simultaneously perform multiplexing
to evaluate other signiﬁcant compounds, primarily HbO2
and HHb.
5. Summary and conclusions
Past and present applications of HSI for the measurement of
in vivo brain metabolism and hemodynamics have been
reviewed: major fundamentals about the approach have been
reported, particularly concerning methodologies for the
quantiﬁcation of the hemodynamic response and of the cer-
ebral oxidative metabolism.
The current hyperspectral technology demonstrates
superior spectral resolution performances in imaging light-
absorbing chromophores, such as HbO2 and HHb, in the
living brain, in comparison to other optical modalities. The
majority of the reported studies has been primarily performed
invasively, by focusing on the exposed cerebral cortex, even
though this procedure has the advantage of providing much
higher spatial resolution, compared to non-invasive techni-
ques such as fNIRS and DOI. Although small animals still
represent the primary targets for monitoring metabolic activ-
ity, investigations in human subjects during neurosurgery are
becoming more and more common and can provide even
more signiﬁcant insights on brain function during a wide
range of responses to stimuli and to various systemic chal-
lenges. In addition, HSI offers the important beneﬁt of
potentially targeting multiple chromophores simultaneously
and perform multiplexed imaging, due to its large spectral
range.
Nonetheless, drawbacks related to HSI are still present
and mostly connected to instrumentation: from the com-
plexity of the imaging equipment to computational issues
related to the large volume of acquired data. Temporal reso-
lution requirements and sensitivity to motion artifacts are also
pushing the favor towards snapshot techniques for hyper-
spectral image acquisition.
The relatively limited amount of publications and studies on
HSI for brain metabolic monitoring may be related to the recent
development of the technique for medical purposes, especially
concerning functional imaging and neuroscience. For a more
detailed and broad review on HSI development and applications
in medical sciences beyond brain imaging, we advise the reader
to look at the review article by Lu et al [1].
Potential future solutions have also been proposed and
discussed, pointing the current HSI approaches towards a
more direct and speciﬁc quantiﬁcation of brain metabolism
that aims at monitoring in vivo cellular energetics and mito-
chondrial ATP production. Such progression in the mapping
of cerebral metabolic activity could exploit the combination
of the assessment of brain hemodynamics with imaging
information provided by speciﬁc metabolites, such as NADH,
FAD and CCO.
In conclusion, biomedical HSI is still a rapidly expanding
ﬁeld and new possible technological improvements could lead
to novel discoveries and enhanced understanding of those
mechanisms which are at the foundations of brain function.
Figure 10. Spatial maps of the relative changes in concentration of HbO2 (ﬁrst row), HHb (second row), scattering (third row), reduced
cytochrome c (fourth row), redCCO (ﬁfth row) and FAD (sixth row) in the exposed cortex of a rat, at different temporal intervals during and
after CSD. The top-right ﬁgure represents the reﬂectance image at 570 nm. Scale bar (in white) equal to 0.5 mm. Reprinted from [95],
Copyright (2013), with permission from Elsevier.
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